Carcinoma of Unknown Primary
📧 Sign up to get email alerts when something new happens for Carcinoma of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-04Clinical Trial Update: SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluated SU5416 (semaxanib), an anti-angiogenic agent, in patients with advanced or recurrent head and neck cancer, carcinoma…
-
CLINICAL_TRIALS trial_result · 2008-01-10Clinical Trial Update: Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site [Phase 2]
This update notes the termination of a Phase 2 study evaluating Carboplatin, Gemcitabine, and Capecitabine in carcinoma of unknown primary.
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary [Phase 3]
A phase 3 clinical trial compares cisplatin alone versus cisplatin plus gemcitabine in patients with carcinoma of unknown primary; the trial…